362 related articles for article (PubMed ID: 26028023)
1. The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.
Chen CC; Kim KH; Lau LF
Oncogene; 2016 Mar; 35(10):1314-23. PubMed ID: 26028023
[TBL] [Abstract][Full Text] [Related]
2. Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.
Kim KH; Chen CC; Monzon RI; Lau LF
Mol Cell Biol; 2013 May; 33(10):2078-90. PubMed ID: 23508104
[TBL] [Abstract][Full Text] [Related]
3. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
[TBL] [Abstract][Full Text] [Related]
4. Matricellular protein CCN1 mediates doxorubicin-induced cardiomyopathy in mice.
Hsu PL; Mo FE
Oncotarget; 2016 Jun; 7(24):36698-36710. PubMed ID: 27167338
[TBL] [Abstract][Full Text] [Related]
5. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.
Feng P; Wang B; Ren EC
Int J Biochem Cell Biol; 2008; 40(1):98-109. PubMed ID: 17698398
[TBL] [Abstract][Full Text] [Related]
6. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
[TBL] [Abstract][Full Text] [Related]
7. PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice.
Qiu W; Wang X; Leibowitz B; Yang W; Zhang L; Yu J
Hepatology; 2011 Oct; 54(4):1249-58. PubMed ID: 21725994
[TBL] [Abstract][Full Text] [Related]
8. Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivo.
Juric V; Chen CC; Lau LF
Mol Cell Biol; 2009 Jun; 29(12):3266-79. PubMed ID: 19364818
[TBL] [Abstract][Full Text] [Related]
9. Higher CYP2E1 Activity Correlates with Hepatocarcinogenesis Induced by Diethylnitrosamine.
Gao J; Wang Z; Wang GJ; Zhang HX; Gao N; Wang J; Wang CE; Chang Z; Fang Y; Zhang YF; Zhou J; Jin H; Qiao HL
J Pharmacol Exp Ther; 2018 May; 365(2):398-407. PubMed ID: 29467309
[TBL] [Abstract][Full Text] [Related]
10. Shear-Induced CCN1 Promotes Atheroprone Endothelial Phenotypes and Atherosclerosis.
Hsu PL; Chen JS; Wang CY; Wu HL; Mo FE
Circulation; 2019 Jun; 139(25):2877-2891. PubMed ID: 30917686
[TBL] [Abstract][Full Text] [Related]
11. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
Sakurai T; Maeda S; Chang L; Karin M
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
[TBL] [Abstract][Full Text] [Related]
12. TNFα-induced apoptosis enabled by CCN1/CYR61: pathways of reactive oxygen species generation and cytochrome c release.
Juric V; Chen CC; Lau LF
PLoS One; 2012; 7(2):e31303. PubMed ID: 22363611
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix protein CCN1 regulates cardiomyocyte apoptosis in mice with stress-induced cardiac injury.
Hsu PL; Su BC; Kuok QY; Mo FE
Cardiovasc Res; 2013 Apr; 98(1):64-72. PubMed ID: 23329650
[TBL] [Abstract][Full Text] [Related]
14. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
15. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
16. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
[TBL] [Abstract][Full Text] [Related]
17. Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis.
Kong B; Zhu Y; Li G; Williams JA; Buckley K; Tawfik O; Luyendyk JP; Guo GL
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(5):G295-302. PubMed ID: 26744468
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents.
Yu LX; Yan HX; Liu Q; Yang W; Wu HP; Dong W; Tang L; Lin Y; He YQ; Zou SS; Wang C; Zhang HL; Cao GW; Wu MC; Wang HY
Hepatology; 2010 Oct; 52(4):1322-33. PubMed ID: 20803560
[TBL] [Abstract][Full Text] [Related]
19. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.
Maeda S; Kamata H; Luo JL; Leffert H; Karin M
Cell; 2005 Jul; 121(7):977-90. PubMed ID: 15989949
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.
Wree A; Johnson CD; Font-Burgada J; Eguchi A; Povero D; Karin M; Feldstein AE
Cell Death Differ; 2015 Dec; 22(12):1985-94. PubMed ID: 25909884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
